Product image of Cutaquig (Human Normal Immunoglobulin) supplied by GNH India

Cutaquig

Active Ingredient:
Human Normal Immunoglobulin
Origin:
EU

Cutaquig (Human Normal Immunoglobulin)

Cutaquig is a subcutaneous immunoglobulin therapy designed to support immune function. Learn about its uses, effects, and precautions for managing immune-related conditions.

Manufacturer / TM Owner

Octapharma (Ip) Sprl

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Cutaquig is primarily used for immune support in individuals with primary immunodeficiency. This therapy helps to replenish antibodies that the body may not produce adequately on its own. People often ask, 'What is Cutaquig used for?' It is commonly prescribed to help prevent infections in those with weakened immune systems.

Side Effects

  • Cutaquig may cause local reactions at the injection site, such as redness, swelling, or itching. Some individuals might experience systemic effects like headache, fatigue, or mild fever. These effects are generally temporary and subside as the body adjusts to the treatment.

Precautions & Warnings

  • Cutaquig should be administered under medical supervision. It is important to monitor for any signs of allergic reactions or severe side effects. Patients should inform their healthcare provider about any pre-existing conditions or medications they are taking before starting this therapy.

Avoid Interactions

  • Cutaquig may interact with certain medications, including those that affect the immune system. It is advisable to avoid alcohol and consult a healthcare provider before combining it with other treatments. Always follow the guidance of a medical professional regarding potential interactions.

Frequently Asked Questions

Cutaquig is used to support immune function in individuals with primary immunodeficiency, helping to prevent infections.

Cutaquig is administered via subcutaneous injection, typically under the guidance of a healthcare professional.

Common side effects may include local reactions at the injection site, such as redness or swelling, and systemic effects like headache or fatigue.

Potential interactions should be discussed with a healthcare provider, as Cutaquig may interact with certain medications.

Individuals with known allergies to immunoglobulin products or those with severe pre-existing conditions should consult a healthcare provider before using Cutaquig.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Human Normal Immunoglobulin

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT